⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215050 | 0.94 | ALDH1A1 (0.35) | — | |
| SCHEMBL4070075 | 0.92 | ALDH1A1 (0.37) | — | |
| SCHEMBL28172935 | 0.88 | ALDH1A1 (0.39) | — | |
| SCHEMBL473647 | 0.87 | — | — | |
| SCHEMBL26462174 | 0.82 | ALDH1A1 (0.39) | — | |
| SCHEMBL15525589 | 0.80 | — | — | |
| SCHEMBL17424767 | 0.79 | — | — | |
| SCHEMBL10738266 | 0.79 | ALDH1A1 (0.41) | — | |
| SCHEMBL20384045 | 0.73 | — | — | |
| SCHEMBL446920 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024166133-A1 | LIGAND SCAFFOLD FOR PROXIMAL & REMOTE BORYLATION OF ARENES | CENTRE OF BIOMEDICAL RESEARCH (IN) | 2024-08-15 | — | — | WO | disclosed |
| US-11312668-B2 | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | ABBVIE INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-20210017100-A1 | ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE | AbbVie Deutschland GmbH & Co. KG (DE) | 2021-01-21 | — | — | US | disclosed |
| US-10836688-B2 | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | ABBVIE INC. (US) | 2020-11-17 | — | — | US | disclosed |
| US-10683256-B2 | Process for preparing substituted biphenyls | BASF SE (DE) | 2020-06-16 | — | — | US | disclosed |
| US-20200148610-A1 | ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE | ABBVIE INC. | 2020-05-14 | — | — | US | disclosed |
| WO-2019174533-A1 | SMALL MOLECULE PD-1/PD-L1 INHIBITOR AND USE THEREOF IN DRUGS | 广东东阳光药业有限公司 | 2019-09-19 | — | — | WO | disclosed |
| US-10407383-B2 | Cyclopentene and cyclopentadiene compounds for controlling invertebrate pests | BASF SE (DE) | 2019-09-10 | — | — | US | disclosed |
| US-20190210954-A1 | Process for Preparing Substituted Biphenyls | LIANHE CHEMICAL TECHNOLOGY CO., LTD (CN) | 2019-07-11 | — | — | US | disclosed |
| US-10327446-B2 | Naphthyl- or isoquinolinyl-substituted isothiazoline compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2019-06-25 | — | — | US | disclosed |
| EP-2055705-A1 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF | Ono Pharmaceutical CO., LTD. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20090105297-A1 | Compounds Modulating C-Kit Activity | PLEXXIKON INC | 2009-04-23 | — | — | US | disclosed |
| US-7498342-B2 | Compounds modulating c-kit activity | PLEXXIKON, INC. (US) | 2009-03-03 | — | — | US | disclosed |
| EP-1083881-B1 | LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents | ALZA CORP (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1176962-B1 | LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION | ALZA CORP (US) | 2004-02-11 | — | — | EP | disclosed |
| EP-1176962-A2 | LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION | Alza Corporation (US) | 2002-02-06 | — | — | EP | disclosed |
| EP-1083881-A2 | LIPOSOME COMPOSITION AND METHOD FOR ADMINISTERING A QUINOLONE | ALZA Corporation (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-2000066126-A2 | LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION | ALZA CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| US-5972379-A | LIPOSOMES HAVING A SURFACE COATING OF HYDROPHILIC POLYMER CHAINS AND AN ENTRAPPED CIPROFLOXACIN-AMINO ACID CONJUGATE, USEFUL FOR TREATING THE BACTERIAL INFECTIONS | SEQUUS PHARMACEUTICALS, INC. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1999051202-A2 | QUINOLONE CONTAINING LIPOSOMES AND THEIR USE AS ANTIBACTERIAL AGENTS | SEQUUS PHARMACEUTICALS, INC. (US) | 1999-10-14 | — | — | WO | disclosed |